Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy

International Journal of Molecular Sciences

Amit K. Maiti¹ 

[1] Department of Genetics and Genomics, Mydnavar, 2645 Somerset Boulevard, Troy, MI 48084, USA;

关键词: diabetes;    nephropathy;    inflammation;    genes;    biomarker;    precision therapy;   

DOI  :  10.3390/ijms22189985

来源: DOAJ

【 摘 要 】

Diabetic Nephropathy (DN) is a debilitating consequence of both Type 1 and Type 2 diabetes affecting the kidney and renal tubules leading to End Stage Renal Disease (ESRD). As diabetes is a world epidemic and almost half of diabetic patients develop DN in their lifetime, a large group of people is affected. Due to the complex nature of the disease, current diagnosis and treatment are not adequate to halt disease progression or provide an effective cure. DN is now considered a manifestation of inflammation where inflammatory molecules regulate most of the renal physiology. Recent advances in genetics and genomic technology have identified numerous susceptibility genes that are associated with DN, many of which have inflammatory functions. Based on their role in DN, we will discuss the current aspects of developing biomarkers and molecular therapy for advancing precision medicine.

【 授权许可】

Unknown